Background: Understanding and detecting imported diseases is a priority in the prevention and management of prevalent and emergent infectious diseases acquired abroad. The þRedivi network measures the burden of imported infections in Spain and is essential for closing the gap in travel medicine. Methods: Demographic characteristics, travel information, syndromes and confirmed travel-related diagnoses were registered in a standardised online database. Results: A total of 10 767 cases of imported infectious diseases were registered between October 2009 and December 2015. Of these, 60.8% of cases were immigrants seen for the first time after arrival, 20.6% were travellers, and 18.4% were individuals visiting friends and relatives (VFR [immigrants and travellers]). The median time between arrival and medical consultation was 5.5 years for immigrants, 2.0 weeks for travellers, 3.1 weeks for VFRtravellers and 11.4 for VFR-immigrants. The most prevalent diagnoses were Chagas disease in immigrants and nonspecific acute diarrhoea in travellers. Malaria by P. falciparum was one of the most prevalent diagnoses among VFR. More than half the travellers saw a physician before travelling, although one-third of those for whom antimalarial medication was indicated did not take their medication correctly. As for VFR, only 10.4% of VFR-immigrants and 32.5% of VFR-travellers sought pre-travel advice. Only 23 and 21%, respectively, of those for whom antimalarial prophylaxis was indicated took the medication properly. Conclusions: þRedivi provides a clear picture of the prevalence of imported infectious diseases among travellers and immigrants in Spain. The data collected could be used to improve everyday health care provided to travellers and immigrants after travel, to guide pre-travel consultations and to monitor the potential occurrence of tropical or exotic infectious diseases.
Introduction
Monitoring migrants and travellers is an essential part of the process for detecting the most frequent travel-related health problems and when reporting on the aetiology, population characteristics and countries of origin of an imported disease. Ideally, surveillance networks could be used for early detection and containment of infectious diseases such as arboviral diseases in travellers and tuberculosis in immigrants. Spain is well situated for the surveillance of travelrelated diseases not only due to its geographical location (between Africa and northern Europe), but also because it receives around 60 million international tourists every year. 1 For many immigrants, Spain is their first port of entry to Europe, and immigrants now account 10% of the total Spanish population. 2 In 2014, 11.8 million Spaniards travelled abroad 3 : 1.1 million to Africa, 764 000 to Central and South America and 520 000 to Asia. 4 Besides, nearly 2.3 million Spanish nationals live abroad, 5 often in tropical and subtropical countries, and return to Spain to visit friends and relatives. Therefore, Spain is an ideal area to analyse the various risk factors for emergence of imported infections. Moreover, climate change may have an impact on the pathogen's vectors, with the potential risk of increasing the area affected by tropical infections. Given its wide geographical representation and steady publication record, the GeoSentinel Surveillance Network has proved extremely useful in the surveillance of travel-related morbidity around the world. GeoSentinel has helped to identify several outbreaks, such as that of leptospirosis among travellers to Borneo in 2000 6 and the possible resurgence of malaria in Greece. 7 However, GeoSentinel had only one cooperative centre in Spain until 2015 (having two centres since then), thus limiting appropriate representation of imported infectious diseases in this country. The epidemiological registries of infectious diseases in Spain, namely, the Minimum Basic Data Set and the Notifiable Diseases Surveillance System, are subject to major limitations when it comes to assessing the burden of travelrelated diseases, since only cases requiring hospitalisation and specific infectious diseases are registered. In addition, published case series may not cover the spectrum of imported diseases in Spain, since information often comes from specialised centres that focus mainly on immigrants and not so much on conventional travellers. Case series may also be limited to specific regions of Spain and not cover the whole country. þRedivi, the Spanish Network for the Study of Infectious Diseases imported by Travellers and Immigrants (Red Cooperativa para el Estudio de Enfermedades Importadas por Viajeros e Inmigrantes), was created with the aim of closing this gap in travel medicine in Spain. þRedivi is a collaborative network of medical centres through which all new cases of imported infectious diseases in Spain are registered in an online database. It comprises both non-specialized centres and centres specialised in tropical medicine based in hospitals and primary care. The aim of the present study was to describe the þRedivi collaborative network and to summarise data gathered prospectively between October 2009 and December 2015. Department at Ram on y Cajal Hospital (Madrid). The initiative began with five centres, and other centres have been joining the network since then. At present, the network comprises 25 medical centres (centres specialised in imported infections and other centres) located in eight different regions of Spain.
The methodology of þRedivi has been published elsewhere 10 . Briefly, members of þRedivi share a common online database where new cases of imported infectious diseases are registered. A data collection sheet is available online. The coordinating centre is in charge of database management and assessment of data quality and monitors adherence to a pre-defined protocol. The database does not contain personal data that identify patients: only the centres have access to the personal and clinical data of the cases they manage. A unique identifier is generated automatically for each new case. Therefore, data in the database cannot be directly linked back to the patient. When recorded cases are deemed to contain errors, the unique identifier is reported by the coordinator to the appropriate centre so that the clinical history can be reviewed and errors amended. Cases recorded in þRedivi are presumed to be an imported infectious disease associated with travel. Exposure during travel, incubation periods and symptoms are taken into account in order to assess the origin of the disease. Returning travellers/immigrants can account for more than one case in the database if they have made various trips and are diagnosed with a second or subsequent imported infectious disease. Approval was obtained from the coordinating centre's ethics committee and local ethics committees.
The variables that appear on the data collection sheet comprise demographic characteristics, clinical and epidemiological data and a brief description of the disease. The demographic characteristics included date of birth, sex, country of birth and main country of residence during the previous 5 years. Clinical and epidemiological data include the type of immunosuppression if applicable, type of traveller, date of first arrival in Spain, length of trip, return date, destination or country of origin for immigrants, risk level, pre-travel consultation when applicable, the presence of antimalarial drug indication, specific antimalarial drug if prescribed and whether this drug was taken appropriately or not. þRedivi classifies persons attending a first consultation as follows: immigrant (person living in Spain but born elsewhere), VFR-immigrant (immigrant travelling back from his/her country of birth after visiting friends and relatives), VFR-traveller (person who travels back from his/her first-degree relative's country of birth) and traveller (conventional international tourist returning from a trip and expatriates). As for risk level, high-risk travellers who do not use the main tourist routes and engage in high-risk activities (e.g. backpackers, hunters and long-stay travellers in close contact with the local population or wildlife such as missionaries, volunteers and tourist guides). Low-risk travel refers to standard tourism involving little contact with locals or short professional trips such as business trips and aircraft crew stays. Finally, the variables recorded to describe the disease episode were date of consultation, reasons for consultation (based on predefined syndromes and symptoms) and final diagnosis. Cases were classified by þRedivi based on 519 available diagnostic codes framed within 22 syndromes.
þRedivi data are easily downloaded and exported for analysis. Datasheets are frequently generated for continuous analysis of data quality and to quantify and describe imported infectious diseases in Spain. The data analysed for the present study summarise cases from þRedivi's collaborative centres between October 2009 and December 2015. A descriptive analysis was performed to assess the gender distribution, age, type of case (immigrant, VFR or traveller), time until first consultation after arrival, immunosuppression status, duration of travel, frequency of pre-travel advice, main reasons for consultation and main diagnosis. Qualitative variables were expressed as relative and absolute frequencies, and quantitative data were expressed as median and 25th and 75th percentiles. Confidence intervals (95%) were calculated. The chi-square and Fisher exact test (when appropriate) were used to compare categorical variables; continuous variables were compared using the t test (when normally distributed) or Mann-Whitney test (when not normally distributed).
Results
In total, 10 767 cases of imported infectious diseases were registered in þRedivi between 1 October 2009 and 31 December 2015; of these, 53% were women. The database included 6550 immigrants, 2218 travellers, 1799 VFR-immigrants and 200 VFR-travellers (Table 1) .
Travellers
The median duration of the trip was 24 days, and most trips-1559 out of 2218 (70.3%)-were considered high-risk trips. The regions most frequently visited were Sub-Saharan Africa (36.6%), South-East Asia (15.7%), South-Central Asia (14.4%), Central America/Caribbean (13.4%) and South America (12.8%). The most frequently visited countries were India (12.3%), Thailand (6.3%), Senegal (4.7%), Indonesia (2.9%), Brazil (2.8%), Equatorial Guinea (2.8%), Peru (2.8%), Mexico (2.5%), Dominican Republic (2.5%), Colombia (2.4%) and Cuba (2.0%).
A total of 1162 (52.4%) travellers received pre-travel advice. Antimalarial prophylaxis was indicated in 688 cases (31.0%), although 230 (33.4%) did not take their medication properly. The most frequently indicated antimalarial drugs were atovaquone-proguanil (n ¼ 388), mefloquine (n ¼ 127), doxycycline (n ¼ 51) and chloroquine (n ¼ 6). Adherence differed significantly by drug: 57.5% of patients with a prescription for atovaquone-proguanil and 45% of those with a prescription for mefloquine took their medication correctly. However, only 31.4% of patients who were prescribed doxycycline and 16.7% of those prescribed chloroquine took their medication correctly (P < 0.001).
Median time between return and medical consultation was 14 (5-43) days. Most travellers (n ¼ 1825) had a single reason for consultation. The main reason in most cases was gastrointestinal syndrome, febrile syndrome or dermatologic syndrome (Table 2) . Of those who presented with more than one reason for consultation (n ¼ 393), most had febrile syndrome along with gastrointestinal syndrome (36.9%), musculoskeletal syndrome (18.1%) or dermatologic syndrome (11.7%).
As for the final diagnosis, 1813 travellers (81.7%) had a single travel-related diagnosis, 335 (15.1%) had two, 61 (2.7%) had three and nine (0.4%) had four. No travellers had five different diagnoses. The 15 most common diagnoses are summarised in Table 3 . Non-specific acute diarrhoea was the most frequent, and when all cases of diarrhoea are grouped together, nearly one out of four travellers had this diagnosis (552/2.218). After non-specific acute diarrhoea, the most frequent diagnoses among travellers were giardiasis, uncomplicated dengue and eosinophilia.
Immigrants
Most immigrants were originally from South America (57.8%), Sub-Saharan Africa (25.8%) and South-Central Asia (5.2%). The most frequent countries of origin were Bolivia (45.2%), Equatorial Guinea (7.7%), Equator (4.2%), Pakistan (3.6%), Senegal (3.5%), Cameroun (2.7%), Nigeria (2.5%), Morocco (2.4%), Colombia (2.3%) and Peru (2.2%).
Median time between arrival in Spain and medical consultation was over 5.5 (1.7-8.8). Most immigrants (n ¼ 5870) had a single reason for consultation. As for 'primary reasons for consultation', the most common was health screening only (asymptomatic) followed by abnormal laboratory results (Table 2) .
In 4472 cases (68.3%), the immigrants had a single travelrelated diagnosis, 1305 (19.9%) had two, 542 (8.3%) had three, 170 (2.6%) had four and 61 (0.9%) had five different diagnoses of imported infectious diseases. Chagas disease was the most frequent diagnosis among immigrants (over 40%), followed by 
Health screening HBV: hepatitis B virus. More than one diagnosis may be recorded for one case; the % is the rate of specific diagnosis among specific type of case.
eosinophilia and latent tuberculosis. The 15 most common diagnoses among immigrants are summarized in Table 3 .
VFR
Most trips among VFR-immigrants (95.6%) and VFR-travellers (94.0%) were considered high-risk. The most frequently visited areas among VFR-immigrants were South America (45.4%), Sub-Saharan Africa (37.1%) and South-Central Asia (7.4%).
The most frequently visited countries were Bolivia (27.9%), Equatorial Guinea (17.2%), Nigeria (7.2%), Ecuador (6.4%), Colombia (5.0%), Pakistan (4.7%) and the Dominican Republic (3.3%). As for VFR-travellers, the most frequently visited areas were Sub-Saharan Africa (42.5%), South-Central Asia (25.5%) and South-America (16.5%), and the most frequent countries were Equatorial Guinea (18.0%), Pakistan (14.5%), India (6.5%), Morocco (6.0%), Bolivia (5.0%), Ecuador (5.0%), Nigeria (5.0%), Bangladesh (4.5%) and Senegal (3.0%). In total, 69 different countries were visited by VFRs. Only 10.4% of VFR-immigrants and 32.5% of VFR-travellers received pre-travel advice. Antimalarial prophylaxis was indicated in 209 (11.6%) and 43 (21.5%) cases, respectively. Of the 209 VFR-immigrants, 48 (22.9%) who had been prescribed antimalarial medication took it correctly. The most frequently prescribed medications were mefloquine (n ¼ 70), atovaquoneproguanil (n ¼ 37) and doxycycline (n ¼ 19). As for VFRtravellers, nine out of 43 (20.9%) took their medication properly. The most commonly prescribed antimalarial drugs in this group were mefloquine (n ¼ 17), atovaquone-proguanil (n ¼ 16) and doxycycline (n ¼ 2). Adherence did not differ significantly between VFR-immigrants (22.9%) and VFR-travellers (20.9%) (P ¼ 0.56) or between the type of antimalarial drug (P ¼ 0.53 for VFR-immigrants and P ¼ 0.66 for VFR-travellers).
The median time between arrival in Spain and medical consultation was 11.4 weeks (2-54.1) for VFR-immigrants and 3.1 weeks (1.1-13.7) for VFR-travellers. Most VFR-immigrants (83.3%) had a single reason for consultation rather than two or more. The most common primary reasons for consultation were febrile syndrome, health screening (asymptomatic) and abnormal laboratory values (Table 2) . Most VFR-travellers (87.5%) had a single reason for consultation. The most frequent primary reasons for consultation in this group were febrile syndrome, gastrointestinal syndrome and abnormal laboratory results.
As for the number of final travel-related diagnoses, 1198 (66.6%) VFR-immigrants had only one, 416 (23.1%) had two, 148 (8.2%) had three, 25 (1.4%) had four and 12 (0.7%) had five different diagnoses. Among VFR-travellers, 159 (79.5%) had one diagnosis, 31 (15.5%) had two, 10 (5.0%) had three and none had more than three different diagnoses. The most common diagnosis in VFR-immigrants was eosinophilia, followed by Chagas disease and malaria caused by P. falciparum. The most frequent diagnosis in VFR-travellers was malaria caused by P. falciparum, followed by eosinophilia and giardiasis. The 15 most common diagnoses among VFR are summarized in Table 3 .
Discussion
þRedivi is the first and only collaborative network recruiting cases of imported infectious diseases in Spain. Over the last seven years, the database has gathered epidemiological and clinical information on over 10 700 cases including travellers, immigrants and VFR. As well as travel information and the usual epidemiological characteristics, þRedivi also collects information on immunosuppression, which is increasingly frequent in Spain. The number of immigrants and long-term travellers is particularly high as a result of the significant number of missionaries and expatriates among travellers and the fact that immigrants are a target population for our centres.
Most goals set when þRedivi was implemented have been met: the number of additional collaborators has increased and there is broad geographical representation of the medical care provided with regard to travel and immigrant medicine, dissemination of knowledge on travel medicine is growing [8] [9] [10] [11] and control of data quality is ensured by the continuous data checking and cleansing undertaken by the coordinating centre. In addition, since þRedivi was integrated into the National Network for Research on Tropical Diseases (RICET, Red de Investigaci on de Centros de Enfermedades Tropicales) in 2012, it has expanded its network considerably by making contact with experts in imported diseases. þRedivi centres are located in the main cities (12 in Barcelona and Madrid), as well as in northern Spain and the Mediterranean area. Therefore, þRedivi provides a comprehensive picture of the impact of imported infections in Spain. þRedivi also reflects the prevalence of less frequent but epidemiologically relevant infectious agents and may be used to describe disease patterns and patient profiles. The analyses made by þRedivi are much more specific for Spain than those of GeoSentinel, which mainly records cases involving tourists and for which only two Spanish centres are represented 12, 13 . þRedivi provides a much greater representation of immigrants, probably because þRedivi centres are public hospitals attending immigrants who frequently travel back and forth between Spain and their country of birth, whereas GeoSentinel centres are mostly private clinics that specialize in travel medicine 13 . Given proximity and cultural bonds, the most frequent VFR travellers registered in þRedivi travel either to Africa or to Latin America. As compared with the GeoSentinel results 14 , our study population had a lower proportion of travellers, with immigrants as the largest group. Even although Latin America and Sub-Saharan Africa are the main regions of origin in both GeoSentinel and þRedivi, Latin-American women account for a significant proportion of cases in þRedivi (immigrants) and their characteristics may differ from those of travellers to Latin America gathered in GeoSentinel. Furthermore, some regions in South-East Asia are more frequently visited by cases gathered in the GeoSentinel series, whereas regions of North Africa may be more significantly represented in þRedivi than in GeoSentinel. These factors may explain some of the differences detected for most common diagnoses (such as Chagas disease) or the high number of examinations performed in þRedivi centres.
In the context of Spanish preventive medicine and public health, a registry such as þRedivi could be used for health care planning and to detect trends before outbreaks. Ideally, þRedivi could prove useful for the rapid detection of significant events, in much the same way as GeoSentinel has done, for example, with East African trypanosomiasis in Eastern Zambia and North Central Zimbabwe 15 . It could also be used to identify and describe the epidemiological characteristics of high-risk populations within the context of an outbreak. Monitoring the frequency of imported infectious diseases may provide useful knowledge for clinicians during pre-travel consultations, which in Spain are almost exclusively in public health centres within the National Health Service. In addition, a better knowledge of the epidemiology of imported diseases may help clinicians providing care for patients returning with an imported disease. Furthermore, information gathered with þRedivi may prove useful when assessing the potential risk of specific tropical or exotic infectious diseases that may be imported by travellers and immigrants such as dengue fever 16 . The health authorities may need to evaluate the presence of vectors and appropriate conditions, as well as the frequency of importation.
Analyses drawn from the þRedivi database are limited to travellers or immigrants seeking health care or health screening at one of the collaborating centres; therefore, not all cases of imported infectious diseases are collected. Furthermore, the relative risk of travel-related diseases cannot be estimated, since not every traveller or immigrant who arrives in the country seeks medical care; consequently, only proportionate morbidity may be estimated. This limitation is characteristic of all registries with a similar methodology, whose data must also be interpreted with caution. In addition, data entry can vary between centres, although this is probably reduced by the use of specific diagnostic codes and a standardised protocol. Moreover, the continuous analysis of the quality of the database performed at the coordinating centre is designed to detect and correct deviations from the study protocol.
In conclusion, þRedivi is a useful tool for expanding knowledge on infectious diseases imported by travellers and immigrants in Spain. Findings drawn from the analysis of the database may help health care providers to make international travel safe and to guide physicians in the evaluation of patients returning from trips and seeking medical care in Spain. Additionally, data may be used for health planning, training of physicians and promotion of health initiatives.
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